Nod to proposal for round-the-year air quality study

NEW DELHI: The Delhi cabinet on Tuesday cleared the department of environment’s proposal to carry out a real-time source apportionment study in Delhi, which will be done through the year to highlight the major sources of pollution in different seasons.

The decision was announced by deputy chief minister Manish Sisodia on Tuesday, who said that the study will be carried out by the University of Washington along with the help of the Delhi Pollution Control Committee (DPCC).

Sisodia said that there are different reasons of pollution throughout the year and once the sources of pollution are known through the study, Delhi government would be able to take steps accordingly.

The project will be completed at a cost of around Rs 1.2 crore within a period of 18 months from the date of commissioning of the study, he said.

“The environment department has decided to grant consultancy job entitled ‘Real time source apportionment study for air pollution in Delhi’ to the Department of Energy, Environmental & Chemical Engineering, University of Washington in St. Louis, on nomination basis by invoking Rule 194, GFR 2017 for a total project cost of $175,000,” said a government statement.

According to officials, the cost of the study will be met out from the Air Ambience Fund being maintained by the DPCC. “A fresh, comprehensive and reliable study is required to enable the Delhi government to plan its actions and install real time pollutant source identification model in the capital,” the statement added.

  • Related Posts

    Glenmark Pharma’s US arm launches Latanoprost’s bioequivalent solution

    Glenmark Pharmaceuticals said that US-based Glenmark Pharmaceuticals Inc. has launched Latanoprost Ophthalmic Solution. The aforementioned solution is bioequivalent and therapeutically equivalent to the reference listed drug Xalatan Ophthalmic Solution of…

    HC denies bail to pharma company owner for manufacturing spurious drugs

    Shimla:  The Himachal Pradesh high court on Monday declined bail to the owner of pharmaceutical company M/s Glenmars Healthcare in the Baddi area of Solan district, from where a huge…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra